Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4421_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Contents
- •Contributors
- •1.6 Mixed Disorders
- •1.7 Isolated Symptoms
- •1.7.1 Snoring
- •1.7.2 Catathrenia
- •1.8 Summary
- •References
- •1.1 Introduction
- •1.2 Obstructive Sleep Apnea
- •1.2.1 Obstructive Sleep Apnea, Adult
- •1.2.2 Obstructive Sleep Apnea, Pediatric
- •1.3 Central Sleep Apnea
- •1.3.5 Primary Central Sleep Apnea
- •1.5 Sleep-Related Hypoxemia Disorder
- •2.7 Summary
- •References
- •3: Health Consequences of Obstructive Sleep Apnea
- •3.1 Cardiovascular Consequences
- •3.1.1 Chronic Heart Failure
- •3.1.2 Systemic Hypertension
- •3.1.3 Coronary Heart Disease
- •3.1.4 Arrhythmias
- •3.1.5 Cerebrovascular Disease
- •3.2 Respiratory Consequences
- •3.2.1 Asthma
- •3.2.3 Pulmonary Embolism
- •3.2.4 Pulmonary Hypertension
- •3.3.1 Diabetes Mellitus
- •3.3.2 Metabolic Syndrome
- •3.3.3 Sexual Dysfunction
- •3.4 Gastrointestinal Consequences
- •3.4.2 Nonalcoholic Fatty Liver Disease
- •3.5 Obstetric Outcomes
- •3.5.2 Gestational Diabetes
- •3.5.4 Maternal Surgical Complications
- •3.6 Perinatal Outcomes
- •3.6.1 Impaired Fetal Growth
- •3.6.2 Preterm Birth
- •3.6.4 Stillbirth
- •3.6.5 NICU Admission
- •3.7 Perioperative Outcomes
- •3.8 Accident-Related Consequences
- •3.9 Cancer-Related Outcomes
- •3.10 Survival Outcomes
- •3.10.1 Overall Mortality
- •3.10.2 Cardiovascular Death
- •3.10.4 Perioperative Mortality
- •References
- •4.1 Patient Case
- •4.2 Introduction
- •4.3 History
- •4.4.1 Oxygen
- •4.4.2 Vascular
- •4.4.3 Endocrine
- •4.6.1 Attention & Executive Function
- •4.6.4 Visual-Spatial
- •4.7 Summary
- •References
- •5.1 Introduction
- •5.2 Obesity
- •5.3 Hypertension
- •5.4 Diabetes Mellitus
- •5.5 Fatty Liver Disease
- •5.6 Conclusions
- •References
- •6.1 Background
- •6.2 History Taking
- •6.3 Physical Examination
- •6.4 Conclusion
- •References
- •Further Reading
- •7.1 Background
- •7.2.2 Screening Tools
- •7.2.3 Diagnostic Tests
- •7.2.7 Clinical Guidelines
- •7.3 Home Sleep Apnea Test (HSAT)
- •7.3.1 Advantages
- •7.3.2 Disadvantages
- •7.3.3 Patient Selection
- •7.3.4 Data Obtained
- •7.3.8 Recommended Follow-Up
- •7.3.9 Clinical Outcomes
- •7.4 Polysomnography (PSG)
- •7.4.1 Patient Selection
- •7.4.4 Follow-Up
- •7.5 Conclusions
- •Further Reading
- •8.1 Introduction
- •8.4 CBCT and OSA
- •8.5.1 CPAP
- •8.5.2 Oral Appliances
- •8.5.3 Maxillomandibular Advancement
- •8.6 Upper Airway Stimulation
- •8.7 Summary
- •References
- •9.1.1.1 Cranial Base Lengthening
- •9.1.1.2 Cranial Base Flexion
- •9.1.5.3 Tongue Growth
- •References
- •10.2.1.1 Cranial Base
- •10.2.1.2 Facial Height
- •10.2.1.4 Pharyngeal Airway Space
- •10.2.1.6 Hyoid Bone Position
- •10.3.1 Maxillary Expansion
- •10.3.1.4 RME for OSA
- •References
- •11.2 Pathophysiology
- •11.3 Clinical Exam
- •11.5 Treatment
- •11.6 Summary
- •References
- •12.1 Introduction
- •12.5 Mask Options
- •12.6.1 Dry Mouth
- •12.6.2 Tangled Tubing
- •12.6.3 Condensation
- •12.6.4 Headgear Problems
- •12.6.6 Ramp
- •12.6.7 Cleaning Equipment
- •12.6.8 Skin Irritation
- •12.6.9 Nasal Congestion
- •12.6.10 Aerophagia
- •12.7 Cleaning Equipment
- •12.7.1 Travel Options
- •References
- •13: Oral Appliance Therapy
- •13.1 Introduction
- •13.2 Terminology
- •13.3.2 Device Designs
- •13.4 Methodology
- •13.7.2 Device Design
- •13.7.5 Non-anatomical Traits
- •13.7.6 Disease Severity
- •13.7.7 Supine Dependency
- •13.12.3 Adherence
- •13.12.4 Mean Disease Alleviation
- •13.13 Long-Term Outcomes
- •13.16 Guidelines
- •References
- •14.1 Introduction
- •14.2 Positional Therapy
- •14.2.1 Weight Loss
- •14.2.2 Nasal EPAP Therapy
- •14.2.3 Oral Pressure Therapy
- •14.2.4 Hypoglossal Nerve Stimulation
- •References
- •15.1 Introduction: Background Information
- •15.4 Preoperative Assessment
- •15.4.1 Physical Examination
- •15.4.2 Polysomnography
- •15.4.3 Clinical History
- •15.5 Preoperative Consent
- •15.6 Preoperative Assessment
- •15.6.1 Surgical Setting
- •15.8 Instrumentation
- •15.8.1 Tonsillectomy
- •15.8.2 Adenoidectomy
- •15.9 Postoperative Management
- •15.9.1 Pain
- •15.9.2 Diet
- •15.9.3 Follow-Up
- •15.10 Expected Outcomes by Population
- •15.10.1 General Population
- •15.10.2 Complex Children
- •15.10.2.1 Obese Children
- •15.10.2.2 Down Syndrome
- •15.10.2.3 Craniofacial Syndromes
- •15.10.2.4 Synchronous Airway Lesion
- •15.11.3 Cardiovascular Parameters
- •15.13 Conclusion
- •References
- •Further Reading
- •16.1 Introduction
- •16.3.1 Anatomic Factors
- •16.8 Summary
- •References
- •17: Palatal Surgery for OSA Patients
- •17.1 Introduction
- •17.2.2 Nasopharyngeal Endoscopy
- •17.2.3 Cephalometrics
- •17.3.1.1 Success Rate of UPPP
- •17.3.1.2 Limitations of UPPP
- •17.3.1.3 Impact of UPPP
- •17.3.1.4 Complications of UPPP
- •17.3.2.2 Z-Palatopharyngoplasty
- •17.3.2.3 Expansion Sphincter Pharyngoplasty
- •References
- •18: Hypopharyngeal Surgery for OSA Patients
- •18.1 Introduction
- •18.2 Historical Perspective
- •18.3 Patient Selection
- •18.4 Physical Exam
- •18.5 Imaging I
- •18.5.1 Imaging
- •18.6 Drug-Induced Sedated Endoscopy
- •18.7 Treatment Algorithm
- •18.8 Procedures
- •18.8.1 Transoral Robotic Surgery
- •18.8.2 Radiofrequency Ablation (RFA)
- •18.8.3 Genioglossus Advancement
- •18.8.4 Tongue Base Suspension
- •18.8.5 Hyoid Suspension
- •18.8.7 Hypoglossal Nerve Stimulators
- •18.9 Future Directions
- •References
- •Suggested Reading
- •19.1.1 Imaging
- •19.2.1.1 Pierre Robin Sequence
- •19.2.1.2 Craniofacial Microsomia
- •19.2.2.1 Crouzon’s Syndrome
- •19.2.2.2 Apert Syndrome
- •19.2.3.1 Treacher Collins Syndrome
- •19.2.3.2 Goldenhar Syndrome
- •19.3 Surgical Correction
- •Bibliography
- •20.1 Introduction
- •20.4.2 Surgical Technique (DOME)
- •20.4.4 Consolidation Phase
- •20.6 Discussion
- •References
- •21.3.3 Maxillomandibular Setback
- •References
- •22.1 Introduction
- •22.3 Results
- •22.3.1 Success Rate
- •22.4 Cases
- •22.5 Discussion
- •22.6 Conclusion
- •References
- •23.1 Patient Evaluation
- •23.1.1 Patient Concerns
- •23.1.4 Facial Evaluation
- •23.1.5 Lateral View
- •23.1.6 Oral Examination
- •23.1.7 Periodontal Evaluation
- •23.1.8 Tongue Assessment
- •23.1.9 Temporomandibular Joint
- •23.1.10 The Nose
- •23.1.11 Oropharyngeal Airway Assessment
- •23.2 Radiographic Evaluation
- •23.2.2 Lateral Cephalometric Radiograph
- •23.2.5 Cephalometric Analysis
- •23.3 Dental Model Analysis
- •23.3.1 Arch Length Measurements
- •23.3.2 Tooth Size Analysis
- •23.3.3 Tooth Position
- •23.3.4 Arch Width Analysis
- •23.3.6 Cuspid-Molar Position
- •23.3.7 Tooth Arch Symmetry
- •23.3.10 Ankylosed Teeth
- •23.4 Summary
- •References
- •24.1 TMJ Articular Disc Displacement
- •24.3 Reactive Arthritis (ReA)
- •24.5 Trauma
- •24.6 TMJ Ankylosis
- •24.7 Other End-Stage TMJ Conditions
- •24.8 Summary
- •References
- •25.1 Background
- •25.2 Treatment Planning Maxillary Surgery
- •25.2.1 Bone Anatomy
- •25.2.2 Vascular Anatomy
- •25.5 Adjunct Procedures
- •25.6 Complications
- •References
- •26: Mandibular Surgical Procedures
- •26.1 Genioplasty Procedures
- •26.2 Osseous Genioplasty
- •26.2.1 Anteroposterior Augmentation
- •26.2.2 Surgical Procedure
- •26.2.3 Anteroposterior Reduction
- •26.2.4 Vertical Augmentation (Downgraft)
- •26.2.5 Vertical Reduction
- •26.3 Alloplastic Augmentations
- •26.3.1 Surgical Procedure
- •26.4 Genioplasty Complications
- •26.5 Mandibular Subapical Procedures
- •26.5.3 Possible Complications
- •26.6 Mandibular Body Surgery
- •26.7.1 Nonunion or Malunion
- •26.7.3 Infections
- •26.7.4 Periodontal Defects
- •26.7.5 Nerve Damage
- •26.8 Mandibular Ramus Surgery
- •26.9 Vertical Ramus Osteotomy
- •26.11.1 Early Relapse
- •26.11.2 Condylar Sag
- •26.11.4 Unfavorable Splits or Fractures
- •26.11.6 Periodontal Defects
- •26.11.8 Nerve Injury
- •26.11.9 Infections
- •26.11.10 Nonunion
- •26.11.11 Bleeding Problems
- •References
- •27.1 Occlusal Plane Alteration
- •27.1.1 History
- •27.2 Corrected Frankfort Horizontal Plane
- •27.3 High Occlusal Plane (HOP) Facial Type
- •27.3.6 MRI Evaluation
- •27.3.7 TMJ Disc Displacement
- •27.3.9 Reactive Arthritis
- •27.3.11 Other End-Stage TMJ Pathologies
- •27.6 Summary
- •References
- •28: Maxillomandibular Advancement
- •28.1.1 Symptoms
- •28.1.3.1 Noninvasive Treatments
- •28.1.3.2 Surgical Interventions
- •28.4.1 Preoperative Medical Assessment
- •28.5 Procedure
- •28.5.1.2 Plates Vs. Screws
- •28.7 Post-MMA Follow-Up Care
- •28.8 Conclusion
- •References
- •29.2.1 CASS Adoption Widespread
- •29.2.2 Overall CASS Accuracy
- •29.2.2.1 Soft-Tissue Prediction Simulators
- •29.2.3 Cost
- •29.4.1 Overall CASS Process
- •29.4.1.1 Step 1: Patient Referral
- •29.4.1.7 Step 7: Procedure
- •29.4.4 Case 3
- •29.5 Conclusion
- •References
- •30.1 Introduction
- •30.2 Preoperative Considerations
- •30.2.1 Surgical Facility
- •30.2.2 Medical Clearance
- •30.2.3 Anesthesia Considerations
- •30.3 Inpatient Postoperative Management
- •30.3.1 Immediate Postoperative Course
- •30.3.2 Acute Pain Management
- •30.3.5 DVT Prophylaxis
- •30.3.6 Nutrition
- •30.3.7 Antibiotics
- •30.4.1 Follow-Up Regimen
- •30.4.2 Postoperative Occlusal Guidance
- •30.5 Conclusion
- •References
- •31.1 Paradigm
- •31.2 Preoperative
- •31.3 Acute Post-surgical
- •31.4 Long-Term Post-surgical
- •References

Maxillomandibular Advancement
455
28
The case shows palatal expansion, which was performed to gain additional transverse width following
presurgical uprighting of the lower teeth on the basal
bone. (See . Figs.28.17, 28.18, 28.19, 28.20, and 28.21).
28.7.5 Case 4: High BMI andSevere OSA
A 54-year-old male with high BMI and severe OSA presented to our practice. The airway was diminished at the
soft palate region. The patient was CPAP-intolerant and
it was ineffective as a management modality. Because of
the patient’s high BMI, the patient was recommended to
seek weight loss prior to surgery. This weight change did
not decrease his AHI sufciently due to the fact that the
airway was still constricted at the soft palate region. No
change in the minimal cross-sectional area was noticed.
After MMA, all signs and symptoms of his OSA was
resolved and the patient was cured, and did not require
further CPAP.The maxilla was advanced 10mm and the
pogonion was advanced 18 mm (while including the
genioglossal advancement). The maxilla was expanded
by 14mm and the patient had his palatal splint removed
at 4months postoperatively. A counterclockwise rotation of 8 degrees was performed to increase the airway.
The minimal cross-sectional area increased from 29mm2
to 340mm2. (See . Figs.28.22, 28.23, and 28.24).
. Fig. 28.15 Panoramic radiograph
. Fig. 28.16 Minimum axial area improved from 88mm2 to 186mm
. Fig. 28.17 Signicant advancement was achieved at the ptery-
goid plates (11mm on the left side and 9mm on the right). A palatal
splint was digitally fabricated and used to achieve stability of the
transverse expansion
2

28
456
R. Movahed
. Fig. 28.18 Airway and volumetric improvement can be appreciated at all levels. MCA improved from 169mm2 to 308mm
. Fig. 28.19 Subapico osteotomy setback of the mandible was performed with rigid xation with genioglossal advancement, which facili-
tated more forward advancement than was otherwise possible
2

Maxillomandibular Advancement
457
28
. Fig. 28.20 Before and after lateral cepholemtric radiograph

28
458
R. Movahed
. Fig. 28.21 Pre- and 1-year postoperative photographs show signicantly improved facial harmony. The patient was cured of OSA

Maxillomandibular Advancement
459
28
. Fig. 28.22 Pre- and postoperative photographs
. Fig. 28.23 Pre- and postoperative lateral cephalometric radiographs

28
460
R. Movahed
. Fig. 28.24 Minimal cross-sectional area increased from 29mm2 to 340mm
28.8 Conclusion
CPAP has long been considered the gold standard
4. Young T, Peppard PE, Gottlieb DJ.Epidemiology of obstructive
5. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S.The
treatment for OSA and is often started rst-line in concert with noninvasive lifestyle modications, particularly for milder cases. The use of oral appliances has
also increased since they are also relatively easy to use
6. Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla
and noninvasive. However, surgical intervention may
be the only effective way to treat OSA for many
patients. Short of tracheostomy, MMA has become a
7. Romero E, Krakow B, Haynes P, Ulibarri V.Nocturia and snor-
denitive, permanent treatment for OSA.MMA as a
denitive treatment for OSA is supported by an abundance of systematic reviews, meta-analyses, and cohort
8. Antic NA, Catcheside P, Buchan C, Hensley M, Naughton MT,
studies. However, more data are needed in the form of
prospective randomized controlled trials and other
research that can inform renements of current practices and innovations. Further modications of the
9. Appleton SL, Vakulin A, McEvoy RD, Vincent A, Martin SA,
MMA technique can optimize its employment, including streamlining of the virtual planning processes.
Education and outreach of referring providers, potential candidate patients, former patients, and improving
10. Stelmach-Mardas M, Mardas M, Iqbal K, Tower RJ, Boeing H,
general awareness in communities will help render it a
more acceptable and preferred treatment modality for
OSA.
References
1. Kryger MH.Fat, sleep, and Charles Dickens: literary and medi-
cal contributions to the understanding of sleep apnea. Clin Chest
Med. 1985;6(4):555–62.
2. Kryger M.Charles Dickens: impact on medicine and society. J
Clin Sleep Med. 2012;8(3):333–8. https://doi.org/10.5664/
jcsm.1930.
3. Bickelmann AG, Burwell CS, Robin ED, Whaley RD. Extreme
obesity associated with alveolar hypoventilation; a Pickwickian
syndrome. Am J Med. 1956;21(5):811–8.
11. Mulgrew AT, Ryan CF, Fleetham JA, Cheema R, Fox N,
12. Stoohs RA, Guilleminault C, Itoi A, Dement WC. Trafc acci-
13. George CF. Reduction in motor vehicle collisions following
14. Howard ME, Desai AV, Grunstein RR, Hukins C, Armstrong
2
sleep apnea: a population health perspective. Am J Respir Crit
Care Med. 2002;165(9):1217–39.
occurrence of sleep-disordered breathing among middle-aged
adults. N Engl J Med. 1993;328(17):1230–5. https://doi.
org/10.1056/NEJM199304293281704.
KM. Increased prevalence of sleep-disordered breathing in
adults. Am J Epidemiol. 2013;177(9):1006–14. https://doi.
org/10.1093/aje/kws342.
ing: predictive symptoms for obstructive sleep apnea. Sleep
Breath. 2010;14(4):337–43. https://doi.org/10.1007/s11325-009-
0310-2.
Rowland S, etal. The effect of CPAP in normalizing daytime
sleepiness, quality of life, and neurocognitive function in patients
with moderate to severe OSA.Sleep. 2011;34(1):111–9.
Grant JF, etal. Undiagnosed obstructive sleep apnea is independently associated with reductions in quality of life in middleaged, but not elderly men of a population cohort. Sleep Breath.
2015;19(4):1309–16. https://doi.org/10.1007/s11325-015-1171-5.
Piorunek T. Quality of life, depression and dietary intake in
obstructive sleep Apnea patients. Health Qual Life Outcomes.
2016;14(1):111. https://doi.org/10.1186/s12955-016-0516-5.
Koehoorn M, etal. The impact of obstructive sleep apnea and
daytime sleepiness on work limitation. Sleep Med. 2007;9(1):42–
53. https://doi.org/10.1016/j.sleep.2007.01.009.
dents in commercial long-haul truck drivers: the inuence of
sleep-disordered breathing and obesity. Sleep. 1994;17(7):619–23.
treatment of sleep apnoea with nasal CPAP. Thorax.
2001;56(7):508–12.
JG, Joffe D, et al. Sleepiness, sleep-disordered breathing, and
accident risk factors in commercial vehicle drivers. Am J Respir
Crit Care Med. 2004;170(9):1014–21. https://doi.org/10.1164/
rccm.200312-1782OC.

Maxillomandibular Advancement
461
28
15. Hillman DR, Murphy AS, Pezzullo L. The economic cost of
sleep disorders. Sleep. 2006;29(3):299–305.
16. Walker SL, Saltman DL, Colucci R, Martin L.Canadian Lung
Association Advisory C.Awareness of risk factors among persons at risk for lung cancer, chronic obstructive pulmonary disease and sleep apnea: a Canadian population-based study. Can
Respir J. 2010;17(6):287–94. https://doi.org/10.1155/2010/426563.
17. Jung Y, Junna MR, Mandrekar JN, Morgenthaler TI. The
National Healthy Sleep Awareness Project Sleep Health
Surveillance Questionnaire as an obstructive sleep Apnea surveillance tool. J Clin Sleep Med. 2017;13(9):1067–74. https://doi.
org/10.5664/jcsm.6724.
18. Sia CH, Hong Y, Tan LWL, van Dam RM, Lee CH, Tan
A.Awareness and knowledge of obstructive sleep apnea among
the general population. Sleep Med. 2017;36:10–7. https://doi.
org/10.1016/j.sleep.2017.03.030.
19. Reuveni H, Tarasiuk A, Wainstock T, Ziv A, Elhayany A, Tal
A.Awareness level of obstructive sleep apnea syndrome during
routine unstructured interviews of a standardized patient by primary care physicians. Sleep. 2004;27(8):1518–25.
20. Fleming WE, Ferouz-Colborn A, Samoszuk MK, Azad A, Lu J,
Riley JS, etal. Blood biomarkers of endocrine, immune, inammatory, and metabolic systems in obstructive sleep apnea. Clin
Biochem. 2016;49(12):854–61. https://doi.org/10.1016/j.clinbio-
chem.2016.05.005.
21. Chen H. Circadian rhythms might be the key joint role in intri-
cate effects among metabolic syndrome, obstructive sleep apnea,
and hypertension. J Clin Hypertens (Greenwich). 2018; https://
doi.org/10.1111/jch.13384.
22. Drager LF, Togeiro SM, Polotsky VY, Lorenzi-Filho
G.Obstructive sleep apnea: a cardiometabolic risk in obesity and
the metabolic syndrome. J Am Coll Cardiol. 2013;62(7):569–76.
https://doi.org/10.1016/j.jacc.2013.05.045.
23. Lochan S.Understanding sleep-disordered breathing as a risk
factor for hypertension and metabolic diseases: implications for
clinical assessment. Can J Cardiovasc Nurs. 2011;21(2):7–14.
24. Onat A, Hergenc G, Yuksel H, Can G, Ayhan E, Kaya Z, etal.
Neck circumference as a measure of central obesity: associations
with metabolic syndrome and obstructive sleep apnea syndrome
beyond waist circumference. Clin Nutr. 2009;28(1):46–51. https://
doi.org/10.1016/j.clnu.2008.10.006.
25. Ahbab S, Ataoglu HE, Tuna M, Karasulu L, Cetin F, Temiz LU,
etal. Neck circumference, metabolic syndrome and obstructive
sleep apnea syndrome; evaluation of possible linkage. Med Sci
Monit. 2013;19:111–7. https://doi.org/10.12659/MSM.883776.
26. Cizza G, de Jonge L, Piaggi P, Mattingly M, Zhao X, Lucassen
E, et al. Neck circumference is a predictor of metabolic syndrome and obstructive sleep apnea in short-sleeping obese men
and women. Metab Syndr Relat Disord. 2014;12(4):231–41.
https://doi.org/10.1089/met.2013.0093.
27. Carneiro G, Zanella MT.Obesity metabolic and hormonal disor-
ders associated with obstructive sleep Apnea and their impact on
the risk of cardiovascular events. Metabolism. 2018; https://doi.
org/10.1016/j.metabol.2018.03.008.
28. Patinkin ZW, Feinn R, Santos M. Metabolic consequences of
obstructive sleep Apnea in adolescents with obesity: a systematic
literature review and Meta-analysis. Child Obes. 2017;13(2):102–
10. https://doi.org/10.1089/chi.2016.0248.
29. Berger G, Berger R, Oksenberg A.Progression of snoring and
obstructive sleep apnoea: the role of increasing weight and time.
Eur Respir J. 2009;33(2):338–45. https://doi.
org/10.1183/09031936.00075408.
30. Li KK, Riley RW, Powell NB, Zonato A.Fiberoptic nasopharyn-
golaryngoscopy for airway monitoring after obstructive sleep
apnea surgery. J Oral Maxillofac Surg. 2000;58(12):1342–5.; ;
discussion 5-6. https://doi.org/10.1053/joms.2000.18255.
31. de Ruiter MHT, Apperloo RC, Milstein DMJ, de Lange
J. Assessment of obstructive sleep apnoea treatment success or
failure after maxillomandibular advancement. Int J Oral
Maxillofac Surg. 2017;46(11):1357–62. https://doi.org/10.1016/j.
ijom.2017.06.006.
32. Katz S, Murto K, Barrowman N, Clarke J, Hoey L, Momoli F,
etal. Neck circumference percentile: a screening tool for pediatric obstructive sleep apnea. Pediatr Pulmonol. 2015;50(2):196–
201. https://doi.org/10.1002/ppul.23003.
33. Shah N, Roux F. The relationship of obesity and obstructive
sleep apnea. Clin Chest Med. 2009;30(3):455–65., , vii. https://
doi.org/10.1016/j.ccm.2009.05.012.
34. Uesugi T, Kobayashi T, Hasebe D, Tanaka R, Ike M, Saito
C. Effects of orthognathic surgery on pharyngeal airway and
respiratory function during sleep in patients with mandibular
prognathism. Int J Oral Maxillofac Surg. 2014;43(9):1082–90.
https://doi.org/10.1016/j.ijom.2014.06.010.
35. Kapur VK, Resnick HE, Gottlieb DJ.Sleep heart health study G.
sleep disordered breathing and hypertension: does self-reported
sleepiness modify the association? Sleep. 2008;31(8):1127–32.
36. Walia HK, Li H, Rueschman M, Bhatt DL, Patel SR, Quan SF,
etal. Association of severe obstructive sleep apnea and elevated
blood pressure despite antihypertensive medication use. J Clin
Sleep Med. 2014;10(8):835–43. https://doi.org/10.5664/jcsm.3946.
37. Torres G, Sanchez-de-la-Torre M, Barbe F.Relationship between
OSA and hypertension. Chest. 2015;148(3):824–32. https://doi.
org/10.1378/chest.15-0136.
38. Reid J, Glew RA, Skomro R, Fenton M, Cotton D, Olatunbosun
F, etal. Sleep disordered breathing and gestational hypertension:
postpartum follow-up study. Sleep. 2013;36(5):717–21B. https://
doi.org/10.5665/sleep.2634.
39. Kucuk U, Kucuk HO, Balta S, Demirkol S. Sleep-disordered
breathing and resistant hypertension (February 2013). Cleve Clin
J Med. 2013;80(6):340. https://doi.org/10.3949/ccjm.80c.06001.
40. Wang AY. Sleep-disordered breathing and resistant hypertension. Semin Nephrol. 2014;34(5):520–31. https://doi.
org/10.1016/j.semnephrol.2014.08.006.
41. Geiger SD, Shankar A. The relationship between sleepdisordered breathing and hypertension in a nationally representative sample. Sleep Disord. 2015;2015:769798. https://doi.
org/10.1155/2015/769798.
42. Sawatari H, Chishaki A, Ando SI. The epidemiology of sleep
disordered breathing and hypertension in various populations.
Curr Hypertens Rev. 2016;12(1):12–7.
43. Eskandari D, Zou D, Grote L, Hoff E, Hedner J.Acetazolamide
reduces blood pressure and sleep-disordered breathing in patients
with hypertension and obstructive sleep Apnea: a randomized
controlled trial. J Clin Sleep Med. 2018;14(3):309–17. https://doi.
org/10.5664/jcsm.6968.
44. Nakamoto T.Sleep-disordered breathing-a real therapeutic target for hypertension, pulmonary hypertension, ischemic heart
disease, and chronic heart failure? J Nippon Med Sch.
2018;85(2):70–7. https://doi.org/10.1272/jnms.2018_85-12.
45. Marin JM, Agusti A, Villar I, Forner M, Nieto D, Carrizo SJ,
et al. Association between treated and untreated obstructive
sleep apnea and risk of hypertension. JAMA. 2012;307(20):2169–
76. https://doi.org/10.1001/jama.2012.3418.
46. Barone DA, Krieger AC.Stroke and obstructive sleep apnea: a
review. Curr Atheroscler Rep. 2013;15(7):334. https://doi.
org/10.1007/s11883-013-0334-8.
47. Camilo MR, Sander HH, Eckeli AL, Fernandes RM, Dos SantosPontelli TE, Leite JP, etal. SOS score: an optimized score to screen

462
R. Movahed
28
acute stroke patients for obstructive sleep apnea. Sleep Med.
2014;15(9):1021–4. https://doi.org/10.1016/j.sleep.2014.03.026.
48. Chen CY, Chen CL, Yu CC.Obstructive sleep apnea is independently associated with arterial stiffness in ischemic stroke
patients. J Neurol. 2015;262(5):1247–54. https://doi.org/10.1007/
s00415-015-7699-2.
49. Ramos AR, Seixas A, Dib SI. Obstructive sleep apnea and
stroke: links to health disparities. Sleep Health. 2015;1(4):244–8.
https://doi.org/10.1016/j.sleh.2015.09.005.
50. Kim Y, Koo YS, Lee HY, Lee SY.Can continuous positive airway
pressure reduce the risk of stroke in obstructive sleep Apnea
patients? A systematic review and Meta-analysis. PLoS One.
2016;11(1):e0146317. https://doi.org/10.1371/journal.
pone.0146317.
51. Koo BB, Bravata DM, Tobias LA, Mackey JS, Miech EJ,
Matthias MS, et al. Observational study of obstructive sleep
Apnea in wake-up stroke: the SLEEP TIGHT study. Cerebrovasc
Dis. 2016;41(5–6):233–41. https://doi.org/10.1159/000440736.
52. Yoshida T, Kuwabara M, Hoshide S, Kario K. Recurrence of
stroke caused by nocturnal hypoxia-induced blood pressure
surge in a young adult male with severe obstructive sleep apnea
syndrome. J Am Soc Hypertens. 2016;10(3):201–4. https://doi.
org/10.1016/j.jash.2016.01.013.
53. Swartz RH, Bayley M, Lanctot KL, Murray BJ, Cayley ML,
Lien K, et al. Post-stroke depression, obstructive sleep apnea,
and cognitive impairment: rationale for, and barriers to, routine
screening. Int J Stroke. 2016;11(5):509–18. https://doi.
org/10.1177/1747493016641968.
54. Ifergane G, Ovanyan A, Toledano R, Goldbart A, Abu-Salame I,
Tal A, etal. Obstructive sleep Apnea in acute stroke: a role for
systemic inammation. Stroke. 2016;47(5):1207–12. https://doi.
org/10.1161/STROKEAHA.115.011749.
55. King S, Cuellar N. Obstructive sleep Apnea as an independent
stroke risk factor: a review of the evidence, stroke prevention
guidelines, and implications for neuroscience nursing practice. J
Neurosci Nurs. 2016;48(3):133–42. https://doi.org/10.1097/
JNN.0000000000000196.
56. Boulos MI, Wan A, Im J, Elias S, Frankul F, Atalla M, et al.
Identifying obstructive sleep apnea after stroke/TIA: evaluating
four simple screening tools. Sleep Med. 2016;21:133–9. https://
doi.org/10.1016/j.sleep.2015.12.013.
57. Johnson KG, Johnson DC.Cognitive dysfunction: another reason to treat obstructive sleep apnea in stroke patients. Sleep Med.
2017;33:191–2. https://doi.org/10.1016/j.sleep.2016.12.014.
58. Chen CY, Ho CH, Chen CL, Yu CC.Nocturnal desaturation is
associated with atrial brillation in patients with ischemic stroke
and obstructive sleep Apnea. J Clin Sleep Med. 2017;13(5):729–
35. https://doi.org/10.5664/jcsm.6594.
59. Mehra R, Bena J, Walia HK.Clarifying the role of hypoxia in
obstructive sleep Apnea as a potential promulgator of atrial
brillation in ischemic stroke. J Clin Sleep Med. 2017;13(5):667–
8. https://doi.org/10.5664/jcsm.6578.
60. Sico JJ, Yaggi HK, Ofner S, Concato J, Austin C, Ferguson J,
et al. Development, validation, and assessment of an ischemic
stroke or transient ischemic attack-specic prediction tool for
obstructive sleep Apnea. J Stroke Cerebrovasc Dis.
2017;26(8):1745–54. https://doi.org/10.1016/j.jstrokecerebrovas-
dis.2017.03.042.
61. Zhao X, Guan J. Autonomic nervous system might be related
with circadian rhythms and have the intricate effects in obstructive sleep apnea with metabolic syndrome. J Clin Hypertens
(Greenwich). 2018; https://doi.org/10.1111/jch.13378.
62. von Allmen DC, Francey LJ, Rogers GM, Ruben MD, Cohen AP,
Wu G, etal. Circadian Dysregulation: the next frontier in obstruc-
tive sleep Apnea research. Otolaryngol Head Neck Surg.
2018;194599818797311 https://doi.org/10.1177/0194599818797311.
63. Zhang Z, Wang C.Immune status of children with obstructive
sleep apnea/hypopnea syndrome. Pak J Med Sci. 2017;33(1):195–
9. https://doi.org/10.12669/pjms.331.11959.
64. Vakil M, Park S, Broder A.The complex associations between
obstructive sleep apnea and auto-immune disorders: a review.
Med Hypotheses. 2018;110:138–43. https://doi.org/10.1016/j.
mehy.2017.12.004.
65. Domagala-Kulawik J, Kwiecien I, Bielicki P, Skirecki T. Faspositive lymphocytes are associated with systemic inammation
in obstructive sleep apnea syndrome. Sleep Breath. 2018; https://
doi.org/10.1007/s11325-018-1713-8.
66. Palamaner Subash Shantha G, Kumar AA, Cheskin LJ, Pancholy
SB.Association between sleep-disordered breathing, obstructive
sleep apnea, and cancer incidence: a systematic review and metaanalysis. Sleep Med. 2015;16(10):1289–94. https://doi.
org/10.1016/j.sleep.2015.04.014.
67. Kechribari I, Georgoulis M, Labrou K, Paraskevopoulos L,
Mourati I, Vagiakis E, etal. Associations between dietary patterns and obstructive sleep apnea severity. Clin Nutr ESPEN.
2018;24:186–7. https://doi.org/10.1016/j.clnesp.2018.01.056.
68. Tuomilehto H, Uusitupa M.Lifestyle changes aiming at weight
loss should always be included in the treatment of obese patients
with obstructive sleep apnea. Sleep. 2014;37(5):1021. https://doi.
org/10.5665/sleep.3682.
69. Kerley CP, Hutchinson K, Bolger K, McGowan A, Faul J,
Cormican L. Serum vitamin D is signicantly inversely associated with disease severity in Caucasian adults with obstructive
sleep Apnea syndrome. Sleep. 2016;39(2):293–300. https://doi.
org/10.5665/sleep.5430.
70. Stelmach-Mardas M, Mardas M, Iqbal K, Kostrzewska M,
Piorunek T.Dietary and cardio-metabolic risk factors in patients
with obstructive sleep Apnea: cross-sectional study. PeerJ.
2017;5:e3259. https://doi.org/10.7717/peerj.3259.
71. Ewing GW, Nwose EU, Ewing EN. Obstructive sleep apnea
management with interactive computer technology and nutrition: two case reports. J Altern Complement Med.
2009;15(12):1379–81. https://doi.org/10.1089/acm.2008.0630.
72. Wheaton AG, Perry GS, Chapman DP, Croft JB.Sleep disordered breathing and depression among U.S. adults: National
Health and nutrition examination survey, 2005-2008. Sleep.
2012;35(4):461–7. https://doi.org/10.5665/sleep.1724.
73. Lang CJ, Appleton SL, Vakulin A, McEvoy RD, Vincent AD,
Wittert GA, etal. Associations of undiagnosed obstructive sleep
Apnea and excessive daytime sleepiness with depression: an
Australian population study. J Clin Sleep Med. 2017;13(4):575–
82. https://doi.org/10.5664/jcsm.6546.
74. Jaffe F, Markov D, Doghramji K.Sleep-disordered breathing: in
depression and schizophrenia. Psychiatry (Edgmont).
2006;3(7):62–8.
75. Reyes-Zuniga M, Castorena-Maldonado A, Carrillo-Alduenda
JL, Perez-Padilla R, Martinez-Estrada A, Gomez-Torres L, etal.
Anxiety and depression symptoms in patients with sleepdisordered breathing. Open Respir Med J. 2012;6:97–103. https://
doi.org/10.2174/1874306401206010097.
76. Relia S, Thompson NR, Mehra R, Moul D, Katzan I, FoldvarySchaefer N, etal. Depression score changes in response to sleep
disordered breathing treatment with positive airway pressure in a
large clinic-based cohort. Sleep Breath. 2018;22(1):195–203.
https://doi.org/10.1007/s11325-018-1626-6.
77. Olaithe M, Bucks RS, Hillman DR, Eastwood PR. Cognitive
decits in obstructive sleep apnea: insights from a meta-review
and comparison with decits observed in COPD, insomnia, and

Maxillomandibular Advancement
463
28
sleep deprivation. Sleep Med Rev. 2018;38:39–49. https://doi.
org/10.1016/j.smrv.2017.03.005.
78. Krysta K, Bratek A, Zawada K, Stepanczak R.Cognitive decits
in adults with obstructive sleep apnea compared to children and
adolescents. J Neural Transm (Vienna). 2017;124(Suppl 1):187–
201. https://doi.org/10.1007/s00702-015-1501-6.
79. Pan YY, Deng Y, Xu X, Liu YP, Liu HG.Effects of continuous
positive airway pressure on cognitive decits in middle-aged
patients with obstructive sleep Apnea syndrome: a Meta-analysis
of randomized controlled trials. Chin Med J. 2015;128(17):2365–
73. https://doi.org/10.4103/0366-6999.163385.
80. Knudsen TB, Laulund AS, Ingerslev J, Homoe P, Pinholt
EM.Improved apnea-hypopnea index and lowest oxygen saturation after maxillomandibular advancement with or without
counterclockwise rotation in patients with obstructive sleep
apnea: a meta-analysis. J Oral Maxillofac Surg. 2015;73(4):719–
26. https://doi.org/10.1016/j.joms.2014.08.006.
81. Montserrat JM, Ferrer M, Hernandez L, Farre R, Vilagut G,
Navajas D, etal. Effectiveness of CPAP treatment in daytime function in sleep apnea syndrome: a randomized controlled study with
an optimized placebo. Am J Respir Crit Care Med. 2001;164(4):
608–13. https://doi.org/10.1164/ajrccm.164.4.2006034.
82. Dong Y, Dai Y, Wei G, Cha L, Li X.Effect of continuous positive airway pressure on blood pressure in hypertensive patients
with coronary artery bypass grafting and obstructive sleep
apnea. Int J Clin Exp Med. 2014;7(11):4308–15.
83. Veasey SC, Guilleminault C, Strohl KP, Sanders MH, Ballard
RD, Magalang UJ.Medical therapy for obstructive sleep apnea:
a review by the medical therapy for obstructive sleep Apnea task
force of the standards of practice Committee of the American
Academy of sleep medicine. Sleep. 2006;29(8):1036–44.
84. Gresova S, Tomori Z, Widdicombe J, Donic V, Kundrik M,
Bacova I, etal. Heart rate variability in hypertension caused by
sleep disordered breathing and its modication by CPAP.Bratisl
Lek Listy. 2011;112(3):125–30.
85. Libman E, Bailes S, Fichten CS, Rizzo D, Creti L, Baltzan M,
etal. CPAP treatment adherence in women with obstructive sleep
Apnea. Sleep Disord. 2017;2017:2760650. https://doi.
org/10.1155/2017/2760650.
86. Olsen S, Smith S, Oei T, Douglas J.Health belief model predicts
adherence to CPAP before experience with CPAP. Eur Respir J.
2008;32(3):710–7. https://doi.org/10.1183/09031936.00127507.
87. Shelgikar AV, Aronovich S, Stanley JJ.Multidisciplinary alternatives to CPAP program for CPAP-intolerant patients. J Clin Sleep
Med. 2017;13(3):505–10. https://doi.org/10.5664/jcsm.6508.
88. Araghi MH, Chen YF, Jagielski A, Choudhury S, Banerjee D,
Hussain S, et al. Effectiveness of lifestyle interventions on
obstructive sleep apnea (OSA): systematic review and metaanalysis. Sleep. 2013;36(10):1553–62., , 62A-62E. https://doi.
org/10.5665/sleep.3056.
89. Okuno K, Sato K, Arisaka T, Hosohama K, Gotoh M, Taga H,
etal. The effect of oral appliances that advanced the mandible
forward and limited mouth opening in patients with obstructive
sleep apnea: a systematic review and meta-analysis of randomised controlled trials. J Oral Rehabil. 2014;41(7):542–54.
https://doi.org/10.1111/joor.12162.
90. Doff MH, Hoekema A, Wijkstra PJ, van der Hoeven JH,
Huddleston Slater JJ, de Bont LG, etal. Oral appliance versus
continuous positive airway pressure in obstructive sleep apnea
syndrome: a 2-year follow-up. Sleep. 2013;36(9):1289–96. https://
doi.org/10.5665/sleep.2948.
91. Fleisher KE, Krieger AC. Current trends in the treatment of
obstructive sleep apnea. J Oral Maxillofac Surg.
2007;65(10):2056–68. https://doi.org/10.1016/j.joms.2006.11.058.
92. Valero A, Alroy G. Hypoventilation in acquired Micrognathia.
Arch Intern Med. 1965;115:307–10.
93. Kuhlo W, Doll E, Franck MC. Successful management of
Pickwickian syndrome using long-term tracheostomy. Dtsch
Med Wochenschr. 1969;94(24):1286–90. https://doi.org/10.105
5/s-0028-1111209.
94. Camacho M, Certal V, Brietzke SE, Holty JE, Guilleminault C,
Capasso R. Tracheostomy as treatment for adult obstructive
sleep apnea: a systematic review and meta-analysis. Laryngoscope.
2014;124(3):803–11. https://doi.org/10.1002/lary.24433.
95. Camacho M, Teixeira J, Abdullatif J, Acevedo JL, Certal V,
Capasso R, etal. Maxillomandibular advancement and tracheostomy for morbidly obese obstructive sleep apnea: a systematic
review and meta-analysis. Otolaryngol Head Neck Surg.
2015;152(4):619–30. https://doi.org/10.1177/0194599814568284.
96. Camacho M, Zaghi S, Chang ET, Song SA, Szelestey B, Certal
V. Mini tracheostomy for obstructive sleep Apnea: an evidence
based proposal. Int J Otolaryngol. 2016;2016:7195349. https://
doi.org/10.1155/2016/7195349.
97. Thatcher GW, Maisel RH.The long-term evaluation of tracheostomy in the management of severe obstructive sleep apnea.
Laryngoscope. 2003;113(2):201–4. https://doi.org/10.1097/00005537-
200302000-00001.
98. Engels PT, Bagshaw SM, Meier M, Brindley PG.Tracheostomy:
from insertion to decannulation. Can J Surg. 2009;52(5):427–33.
99. Haapaniemi JJ, Laurikainen EA, Halme P, Antila J.Long-term
results of tracheostomy for severe obstructive sleep apnea syndrome. ORL J Otorhinolaryngol Relat Spec. 2001;63(3):131–6.
https://doi.org/10.1159/000055728.
100. Lewis MR, Ducic Y.Genioglossus muscle advancement with the
genioglossus bone advancement technique for base of tongue
obstruction. J Otolaryngol. 2003;32(3):168–73.
101. Holty JE, Guilleminault C.Maxillomandibular advancement for
the treatment of obstructive sleep apnea: a systematic review and
meta-analysis. Sleep Med Rev. 2010;14(5):287–97. https://doi.
org/10.1016/j.smrv.2009.11.003.
102. Riley RW, Powell NB, Guilleminault C. Obstructive sleep apnea
syndrome: a surgical protocol for dynamic upper airway reconstruction. J Oral Maxillofac Surg. 1993;51(7):742–7; discussion 8-9.
103. Sher AE, Schechtman KB, Piccirillo JF.The efcacy of surgical
modications of the upper airway in adults with obstructive
sleep apnea syndrome. Sleep. 1996;19(2):156–77.
104. Walker-Engstrom ML, Tegelberg A, Wilhelmsson B, Ringqvist I.
4-year follow-up of treatment with dental appliance or uvulopalatopharyngoplasty in patients with obstructive sleep apnea: a
randomized study. Chest. 2002;121(3):739–46.
105. Larrosa F, Hernandez L, Morello A, Ballester E, Quinto L,
Montserrat JM.Laser-assisted uvulopalatoplasty for snoring:
does it meet the expectations? Eur Respir J. 2004;24(1):66–70.
106. Choi JH, Kim EJ, Kim KW, Ju YH, Park EH, Lee SH.Palatal
implants for persistent snoring and mild obstructive sleep apnea
after laser-assisted uvulopalatoplasty. Clin Exp Otorhinolaryngol.
2014;7(1):66–8. https://doi.org/10.3342/ceo.2014.7.1.66.
107. Ferguson KA, Heighway K, Ruby RR.A randomized trial of
laser-assisted uvulopalatoplasty in the treatment of mild obstructive sleep apnea. Am J Respir Crit Care Med. 2003;167(1):15–9.
https://doi.org/10.1164/rccm.2108050.
108. Yonekura A, Kawakatsu K, Suzuki K, Nishimura T.Laser
midline glossectomy and lingual tonsillectomy as treatments
for sleep apnea syndrome. Acta Otolaryngol Suppl.
2003;550:56–8.
109. Mickelson SA, Rosenthal L.Midline glossectomy and epiglottidectomy for obstructive sleep apnea syndrome. Laryngoscope.
1997;107(5):614–9.

464
R. Movahed
28
110. Bowden MT, Kezirian EJ, Utley D, Goode RL. Outcomes of
hyoid suspension for the treatment of obstructive sleep apnea.
Arch Otolaryngol Head Neck Surg. 2005;131(5):440–5. https://
doi.org/10.1001/archotol.131.5.440.
111. Li KK, Guilleminault C, Riley RW, Powell NB.Obstructive sleep
apnea and maxillomandibular advancement: an assessment of
airway changes using radiographic and nasopharyngoscopic
examinations. J Oral Maxillofac Surg. 2002;60(5):526–30; discussion 31.
112. Chang KK, Kim KB, McQuilling MW, Movahed R.Fluid structure interaction simulations of the upper airway in obstructive
sleep apnea patients before and after maxillomandibular advancement surgery. Am J Orthod Dentofac Orthop. 2018;153(6):895–
904. https://doi.org/10.1016/j.ajodo.2017.08.027.
113. Boyd SB, Chigurupati R, Cillo JE Jr, Eskes G, Goodday R,
Meisami T, et al. Maxillomandibular advancement improves
multiple health-related and functional outcomes in patients with
obstructive sleep Apnea: a Multicenter study. J Oral Maxillofac
Surg. 2018; https://doi.org/10.1016/j.joms.2018.06.173.
114. Buttereld KJ, Marks PL, McLean L, Newton J.Quality of life
assessment after Maxillomandibular advancement surgery for
obstructive sleep Apnea. J Oral Maxillofac Surg. 2016;74(6):1228–
37. https://doi.org/10.1016/j.joms.2016.01.043.
115. Baherimoghaddam T, Oshagh M, Naseri N, Nasrbadi NI,
Torkan S.Changes in cephalometric variables after orthognathic
surgery and their relationship to patients' quality of life and satisfaction. J Oral Maxillofac Res. 2014;5(4):e6. https://doi.
org/10.5037/jomr.2014.5406.
116. Nicodemo D, Pereira MD, Ferreira LM.Effect of orthognathic
surgery for class III correction on quality of life as measured by
SF-36. Int J Oral Maxillofac Surg. 2008;37(2):131–4. https://doi.
org/10.1016/j.ijom.2007.07.024.
117. Lye KW, Waite PD, Meara D, Wang D.Quality of life evaluation
of maxillomandibular advancement surgery for treatment of
obstructive sleep apnea. J Oral Maxillofac Surg. 2008;66(5):968–
72. https://doi.org/10.1016/j.joms.2007.11.031.
118. Boyd SB, Walters AS, Waite P, Harding SM, Song Y.Long-term
effectiveness and safety of Maxillomandibular advancement for
treatment of obstructive sleep Apnea. J Clin Sleep Med.
2015;11(7):699–708. https://doi.org/10.5664/jcsm.4838.
119. Caples SM, Rowley JA, Prinsell JR, Pallanch JF, Elamin MB,
Katz SG, et al. Surgical modications of the upper airway for
obstructive sleep apnea in adults: a systematic review and metaanalysis. Sleep. 2010;33(10):1396–407.
120. Marrone O, Vicini C.Upper airway surgery in OSA.European
Respiratory Monograph. 2010;50:286.
121. Zaghi S, Holty JE, Certal V, Abdullatif J, Guilleminault C,
Powell NB, etal. Maxillomandibular advancement for treatment
of obstructive sleep Apnea: a Meta-analysis. JAMA Otolaryngol
Head Neck Surg. 2016;142(1):58–66. https://doi.org/10.1001/
jamaoto.2015.2678.
122. Liu SY, Huon LK, Powell NB, Riley R, Cho HG, Torre C, etal.
Lateral Pharyngeal Wall tension after Maxillomandibular
advancement for obstructive sleep Apnea is a marker for surgical
success: observations from drug-induced sleep endoscopy. J Oral
Maxillofac Surg. 2015;73(8):1575–82. https://doi.org/10.1016/j.
joms.2015.01.028.
123. Elshaug AG, Moss JR, Southcott AM, Hiller JE.Redening success in airway surgery for obstructive sleep apnea: a meta analysis
and synthesis of the evidence. Sleep. 2007;30(4):461–7.
124. Vicini C, Dallan I, Campanini A, De Vito A, Barbanti F,
Giorgiomarrano G, etal. Surgery vs ventilation in adult severe
obstructive sleep apnea syndrome. Am J Otolaryngol.
2010;31(1):14–20. https://doi.org/10.1016/j.amjoto.2008.09.002.
125. Dattilo DJ, Drooger SA.Outcome assessment of patients undergoing maxillofacial procedures for the treatment of sleep apnea:
comparison of subjective and objective results. J Oral Maxillofac
Surg. 2004;62(2):164–8.
126. Cohen-Levy J, Petelle B, Vieille E, Dumitrache M, Fleury
B. Changes in facial prole after maxillomandibular advancement surgery for obstructive sleep apnea syndrome. Int Orthod.
2013;11(1):71–92. https://doi.org/10.1016/j.ortho.2012.12.009.
127. Abramson Z, Susarla SM, Lawler M, Bouchard C, Troulis M,
Kaban LB. Three-dimensional computed tomographic airway
analysis of patients with obstructive sleep apnea treated by maxillomandibular advancement. J Oral Maxillofac Surg.
2011;69(3):677–86. https://doi.org/10.1016/j.joms.2010.11.037.
128. Li KK, Powell NB, Riley RW, Zonato A, Gervacio L,
Guilleminault C.Morbidly obese patients with severe obstructive sleep apnea: is airway reconstructive surgery a viable treatment option? Laryngoscope. 2000;110(6):982–7. https://doi.
org/10.1097/00005537-200006000-00019.
129. John CR, Gandhi S, Sakharia AR, James TT.Maxillomandibular
advancement is a successful treatment for obstructive sleep
apnoea: a systematic review and meta-analysis. Int J Oral
Maxillofac Surg. 2018; https://doi.org/10.1016/j.
ijom.2018.05.015.
130. Buttereld KJ, Marks PL, McLean L, Newton J. Linear and
volumetric airway changes after maxillomandibular advancement for obstructive sleep apnea. J Oral Maxillofac Surg.
2015;73(6):1133–42. https://doi.org/10.1016/j.joms.2014.11.020.
131. Liao YF, Chiu YT, Lin CH, Chen YA, Chen NH, Chen
YR.Modied maxillomandibular advancement for obstructive
sleep apnoea: towards a better outcome for Asians. Int J Oral
Maxillofac Surg. 2015;44(2):189–94. https://doi.org/10.1016/j.
ijom.2014.09.013.
132. Schendel SA, Broujerdi JA, Jacobson RL. Three-dimensional
upper-airway changes with maxillomandibular advancement for
obstructive sleep apnea treatment. Am J Orthod Dentofac
Orthop. 2014;146(3):385–93. https://doi.org/10.1016/j.
ajodo.2014.01.026.
133. Boyd SB, Walters AS, Song Y, Wang L.Comparative effectiveness of maxillomandibular advancement and uvulopalatopharyngoplasty for the treatment of moderate to severe obstructive
sleep apnea. J Oral Maxillofac Surg. 2013;71(4):743–51. https://
doi.org/10.1016/j.joms.2012.10.003.
134. Serra MM, Greenburg D, Barnwell M, Fallah D, Keith K,
Mysliwiec V.Maxillomandibular advancement as surgical treatment for obstructive sleep apnea in active duty military personnel: a retrospective cohort. Mil Med. 2012;177(11):1387–92.
135. Lin CH, Liao YF, Chen NH, Lo LJ, Chen YR. Threedimensional computed tomography in obstructive sleep apneics
treated by maxillomandibular advancement. Laryngoscope.
2011;121(6):1336–47. https://doi.org/10.1002/lary.21813.
136. Blumen MB, Buchet I, Meulien P, Hausser Hauw C, Neveu H,
Chabolle F.Complications/adverse effects of maxillomandibular
advancement for the treatment of OSA in regard to outcome.
Otolaryngol Head Neck Surg. 2009;141(5):591–7. https://doi.
org/10.1016/j.otohns.2009.08.025.
137. Fairburn SC, Waite PD, Vilos G, Harding SM, Bernreuter W,
Cure J, et al. Three-dimensional changes in upper airways of
patients with obstructive sleep apnea following maxillomandibular advancement. J Oral Maxillofac Surg. 2007;65(1):6–12.
https://doi.org/10.1016/j.joms.2005.11.119.
138. Goh YH, Lim KA.Modied maxillomandibular advancement
for the treatment of obstructive sleep apnea: a preliminary
report. Laryngoscope. 2003;113(9):1577–82. https://doi.
org/10.1097/00005537-200309000-00031.
Соседние файлы в папке Библиотека им академика М.И. Перельмана
